Jobs / United States / Glaxosmithkline LLC
Head of RNA Biology
Glaxosmithkline LLC · 🇺🇸 San Diego Science Center Drive
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme. We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work. Discover more about our company wide benefits and life at GSK on our webpage Life at GSK | GSK Head of RNA Biology RNA is one of the most promising and least understood frontiers in drug discovery - and GSK is building the function to lead it. Reporting to the Head of Genetic Medicines Discovery, the successful candidate will define and own the strategy for GSK's RNA Biology function, building deep understanding of the RNA regulome and its role in disease pathology. This is a senior scientific and organizational leadership role with global accountability, requiring deep expertise in RNA biology and in how therapeutic oligonucleotides can intervene in that biology. The role carries responsibility for high-performing teams, external partnerships, and a multidisciplinary, matrixed delivery strategy across GSK. Responsibilities This role offers the opportunity to shape a new scientific function from the ground up and lead activities that will define the next stage of your career. Responsibilities include: • Define and own GSK's RNA biology strategy, establishing RNA as a tractable and well-understood therapeutic target class aligned to the therapeutic priorities of the GSK therapy areas. • Lead mechanistic structure-function elucidation of therapeutically relevant RNAs, connecting secondary and tertiary structure to function and therapeutic intervention. • Map the RNA regulome - transcriptional and post-transcriptional regulatory networks, RNA-binding protein interactions, and RNA modifications - to identify and prioritize points of therapeutic intervention. • Establish the role of non-coding RNA (lncRNA, miRNA, circRNA) in disease pathology, building causal target validation packages that link ncRNA biology to disease mechanism.. • Partner with chemistry, delivery, DMPK, and CMC colleagues across Genetic Medicines Discovery to translate mechanistic insight into improved molecules and development candidates. • Lead the development of an RNA Center of Excellence within GSK, establishing the capability, talent, and infrastructure that make RNA biology an enterprise-level asset adopted across discovery and early development. • Act as a visible scientific ambassador for GSK externally - representing the RNA Biology function at conferences, with academic partners, and across the San Diego life sciences ecosystem to attract talent, ideas, and collaborations. • Establish and manage strategic external collaborations with academic groups, institutes, and technology providers in RNA structural biology, regulome mapping, and non-coding RNA disease biology, with a particular focus on building GSK's presence and reputation within the San Diego RNA research community. • Sit on the Genetic Medicines Discovery leadership team, contribute to the overall Therapeutic Oligo Strategy for GSK, and represent RNA Biology on internal portfolio governance committees. • Build, develop, and retain high-performing, diverse teams with strong scientific rigor and translational focus. Why You? This is a rare chance to build and lead an RNA Center of Excellence from the ground up, with the visibility, resources, and mandate to shape how GSK approaches RNA as a therapeutic target class - and to represent that work externally as a recognized voice in the field. Basic Qualifications